Paper42777046PubMed
Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.
Wu Q and 10 others. Sci Adv, 2026.
Cite this record
ConductScience Library. Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination. Papers, record 42777046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42777046
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.
- Journal
- Sci Adv
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-09-25
Source PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimicrobial Peptides | Major topic |
| Macrophages | Major topic |
| Mycobacterium | Major topic |
| Drug Delivery Systems | Major topic |
| Animals | |
| Mice | |
| Mycobacterium tuberculosis | |
| Mycobacterium smegmatis | |
| Photorhabdus | |
| Mycobacterium bovis | |
| Macrophages, Alveolar |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23060610 | CD-HIT: accelerated for clustering the next-generation sequencing data. | Bioinformatics | 2012 | https://conductscience.org/library/papers/23060610 | PubMed |
| 2 | 35489657 | Strategies for improving antimicrobial peptide production. | Biotechnol Adv | 2022 | https://conductscience.org/library/papers/35489657 | PubMed |
| 3 | 18691913 | Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. | Immunity | 2008 | https://conductscience.org/library/papers/18691913 | PubMed |
| 4 | 39412514 | Intestinal microbiome dysbiosis increases Mycobacteria pulmonary colonization in mice by regulating the Nos2-associated pathways. | Elife | 2024 | https://conductscience.org/library/papers/39412514 | PubMed |
| 5 | 36905712 | Antimicrobial peptides for combating drug-resistant bacterial infections. | Drug Resist Updat | 2023 | https://conductscience.org/library/papers/36905712 | PubMed |
| 6 | 39887565 | Tuberculosis: An Update for the Clinician. | Respirology | 2025 | https://conductscience.org/library/papers/39887565 | PubMed |
| 7 | 28852964 | PPAR-γ and Akt regulate GLUT1 and GLUT3 surface localization during Mycobacterium tuberculosis infection. | Mol Cell Biochem | 2018 | https://conductscience.org/library/papers/28852964 | PubMed |
| 8 | 29589538 | Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes? | Curr Pharm Des | 2018 | https://conductscience.org/library/papers/29589538 | PubMed |
| 9 | 10611360 | Mycobacterial infection of macrophages results in membrane-permeable phagosomes. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10611360 | PubMed |
| 10 | 36924097 | Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics. | Protein Pept Lett | 2023 | https://conductscience.org/library/papers/36924097 | PubMed |
| 11 | 28890547 | Innate immunity in tuberculosis: host defense vs pathogen evasion. | Cell Mol Immunol | 2017 | https://conductscience.org/library/papers/28890547 | PubMed |
| 12 | 38147812 | Antimicrobial peptides: An alternative to traditional antibiotics. | Eur J Med Chem | 2024 | https://conductscience.org/library/papers/38147812 | PubMed |
| 13 | 22851964 | PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing. | PPAR Res | 2012 | https://conductscience.org/library/papers/22851964 | PubMed |
| 14 | 39287392 | Elucidating the molecular properties and anti-mycobacterial activity of cysteine peptidase domain of D29 mycobacteriophage endolysin. | J Virol | 2024 | https://conductscience.org/library/papers/39287392 | PubMed |
| 15 | 10573420 | Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. | Nature | 1999 | https://conductscience.org/library/papers/10573420 | PubMed |
| 16 | 38730558 | Optimized expression of Peptidyl-prolyl cis/transisomerase cyclophilinB with prokaryotic toxicity from Sporothrix globosa. | J Ind Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/38730558 | PubMed |
| 17 | 36982277 | Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982277 | PubMed |
| 18 | 38705792 | [Update on the treatment of tuberculosis]. | Med Clin (Barc) | 2024 | https://conductscience.org/library/papers/38705792 | PubMed |
| 19 | 23329690 | MAFFT multiple sequence alignment software version 7: improvements in performance and usability. | Mol Biol Evol | 2013 | https://conductscience.org/library/papers/23329690 | PubMed |
| 20 | 36195597 | Expression strategies for the efficient synthesis of antimicrobial peptides in plastids. | Nat Commun | 2022 | https://conductscience.org/library/papers/36195597 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42777046
GET https://conductscience.org/api/papers/v1/42777046/references?page=2